ALLOVIR, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 2.02. Results of Operations and Financial Condition.

On January 9, 2023, AlloVir, Inc. (the "Company") issued the press release referred to in Item 7.01 of this Current Report on Form 8-K, which announced that its unaudited cash balance totaled $234 million as of December 31, 2022.

Item 7.01. Regulation FD Disclosure.

The Company is furnishing a press release, attached as Exhibit 99.1, to this Current Report on Form 8-K. The information in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit
  No.       Description

99.1          AlloVir, Inc. press release issued January 9, 2023.

104         Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses